BRIEF — Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Oct 13 (Reuters) — Wuhan Hiteck Biological Pharma Co Ltd: Wuhan Hiteck Biological Pharma Co - Grants Visara Exclusive Rights To Ht006.2.2 Outside Greater China Wuhan Hiteck Biological Pharma Co - To Receive Upfront Payment, Milestone Payments, And Tiered Royalties Wuhan Hiteck Biological Pharma Co - Phase 1b Study Show